Bridge from

Science to Business

Diagenics is a biopharmaceutical company located in Schengen, Luxembourg

 

Our unique business model strives to build a Bridge from Science to Business™
Deutsch (DE-CH-AT)English (United Kingdom)
Welcome to Diagenics

Bridge from Science to Business

Diagenics is a biopharmaceutical company located in Schengen, Luxembourg, with its Germand Headquarters in Essen, Germany. Our unique business model strives to build a Bridge from Science to Business™.

In this way we aspire to a leading position in the diagnostic field. We are currently focussing on the detection of heart infarction through a new and patented heartmarker.

More...

 
News
upgrade UPGRADE-Study Additional Diagnosis opportunities with the novel cardiac marker GPBB
upgrade Acute infarction detection can be acceleratedRenovated troponin products are complemented with a new method: GPBB
upgrade Product launch in Germany and Austria

Diagenics International Corporation announces the market introduction of the DIACORDON™

More...